Regarded as the gold standard in cytocentrifugation, Cytospin is used in thousands of laboratories and a range of applications, and is cited extensively in published papers around the world.
Epredia was established in July 2019 from the acquisition by the PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Powered by the trusted legacy brands such as Shandon, Microm and Menzel Gläser, Epredia has a wide breadth of solutions that have and will continue to transform the anatomical pathology market.
The extensive Epredia portfolio of high-quality instruments, consumables and microscope slides facilitates the efficient processing and accurate diagnosis of precious patient specimens. The legacy of the Epredia Cytospin is long – from the launch of the very first Shandon Cytospin in 1967 to the Epredia Cytospin 4 in the present day.
Learn more about Cytospin technology in the August issue of Pathology in Practice